IGC Pharma (IGC) Other Working Capital Changes (2010 - 2025)
IGC Pharma (IGC) reported Other Working Capital Changes of -$1.1 million for Q3 2025, down 107800.0% year-over-year from N/an in Q3 2024, and down 53750.0% quarter-over-quarter from -$2000.0 in Q2 2025.
IGC Pharma (IGC) Other Working Capital Changes (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Other Working Capital Changes data on file, last reported at -$1.1 million in Q3 2025.
- Other Working Capital Changes for Q3 2025 came in at -$1.1 million, down 107800.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.1 million (down 1601.49% YoY), and the FY2026 annual result was -$2000.0, up 97.3% from the prior year.
- Other Working Capital Changes retreated to -$1.1 million in Q3 2025 per IGC's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $441000.0 in Q4 2022 and troughed at -$1.1 million in Q3 2025.
- A 5-year average of -$93210.5 and a median of -$30000.0 in 2021 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes soared 1570.0% in 2022, then plunged 107800.0% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$30000.0 in 2021, then soared by 1570.0% to $441000.0 in 2022, then sank by 121.09% to -$93000.0 in 2023, then surged by 37.63% to -$58000.0 in 2024, then plunged by 1756.9% to -$1.1 million in 2025.
- Business Quant data shows IGC's Other Working Capital Changes at -$1.1 million in Q3 2025, -$2000.0 in Q2 2025, and -$3000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.08 Mn |
| Sep 30, 2025 | -1.08 Mn |
| Jun 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -58,000.00 |
| Dec 31, 2024 | -58,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | -93,000.00 |
| Dec 31, 2023 | -93,000.00 |
| Sep 30, 2023 | -43,000.00 |
| Sep 30, 2023 | -43,000.00 |
| Jun 30, 2023 | -33,000.00 |
| Jun 30, 2023 | -33,000.00 |